Serum hyaluronan and aminoterminal propeptide of type III procollagen: Variation with age

References

• Dahl L B., Dahl I MS, Engström-Laurent A, Granath. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985; 44: 817–20
   PubMed Web of Science ®Google Scholar
• Reed R K., Lilja K, Laurent T C. Hyaluronan in the rat with special reference to the skin. Acta Physiol Scand 1988; 134: 405–11
   PubMedGoogle Scholar
• Laurent U BG, Laurent T C. On the origin of hyaluronate in blood. Biochem Int 1981; 2: 195–9
   Google Scholar
• Fraser J RE, Kimpton W G., Laurent T C., Cahill R NP, Vakakis N. Uptake and degradation of hyaluronan in lymphatic tissue. Biochem J 1988; 256: 153–8
   PubMed Web of Science ®Google Scholar
• Smedsröd B, Pertoft H, Eriksson S, Fraser J RE, Laurent T C. Studies in vitro on the uptake and degradation of sodium hyaluronate in rat liver. Biochem J 1984; 223: 617–26
   PubMed Web of Science ®Google Scholar
• Fraser J RE, Alcorn D, Laurent T C., Robinson A D., Ryan G B. Uptake of circulating hyaluronic acid by the rat liver. Cellular localization in situ. Cell Tissue Res 1985; 242: 505–10
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Laurent U BG, Lilja K, Laurent T C. Concentration of sodium hyaluronate in serum. Scand J Clin Lab Invest. 1985; 45: 497–504
   PubMed Web of Science ®Google Scholar
• Lindqvist U, Chichibu K, Delpcch B, Goldberg R L., Knudson W, Poole A R., Laurent T C. A comparative study of seven different assays for hyaluronan. Clin Chem 1992; 38: 117–132
   Web of Science ®Google Scholar
• Engström-Laurent A, Hällgren R. Circulating hyaluronate in rheumatoid arthritis: relationship to inflammatory activity and the effect of corticosteroid therapy. Ann Rheum Dis 1985; 44: 83–8
   PubMed Web of Science ®Google Scholar
• Hörslev-Petersen K, Bentsen K D., Engström-Laurent A, Junker P, Halberg P, Lorenzen I. Serum aminoterminal type III procollagen peptide and serum hyaluronan in rheumatoid arthritis: Relation to clinical and serological parameters of inflammation during 8 and 24 months' treatment with levamisole, penicillamine or azathioprine. Ann Rheum Dis 1988; 47: 116–26
   PubMed Web of Science ®Google Scholar
• Seibel M J., Raimann S, Seglias J, Lautenschläger J, Müller W. Serum-Hyaluronsäure and amino-terminales Prokollagen-III-Peptid bei entzünd-lichcn und degenerativen Gelenkerkranungen. Z Rheumatologie 1988; 47: 98–106
   PubMed Web of Science ®Google Scholar
• Lundin Å, Engström-Laurent A, Hällgren R, Michaelsson G. Circulating hyaluronate in psoriasis. Br J Dermatol 1985; 112: 663–71
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Feltelius N, Hällgren R, Wasteson Å. Raised serum hyaluronate in scleroderma: an effect of growth factor induced activation of connective tissue cells. Ann Rheum Dis 1985; 44: 614–21
   PubMed Web of Science ®Google Scholar
• Hörslev-Petersen K, Ammitzböll T, Engström-Laurent A, Bentsen K, Junker P, Asboe-Hansen G, Lorcnzen I. Serum and urinary aminotcrminal type III procollagen peptide in progressive systemic sclerosis: Relationship to scleroderma! involvement, serum hyaluronan and urinary collagen metabolites. J Rheumatol 1988; 15: 460–7
   PubMed Web of Science ®Google Scholar
• Engström-Laurent A, Lööf L, Nyberg A, Schröder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985; 5: 638–42
   PubMed Web of Science ®Google Scholar
• Frebourg T, Delpech B, Bercoff E, Senant J, Bertrand P, Deugnier Y, Boureille J. Serum hyaluronate in liver diseases: study by enzymo-immunological assay. Hepatology 1986; 6: 392–5
   PubMed Web of Science ®Google Scholar
• Nyberg A, Engström-Laurent A, Lööf L. Serum hyaluronate in primary biliary cirrhosis–a biochemical marker for progressive liver damage. Hepatology 1988; 8: 142–6
   PubMed Web of Science ®Google Scholar
• Mattson L, Lindqvist U, Weiland O, Åberg B. Serum levels of the aminoderminal propeptide of type III procollagen and hyaluronan during resolving and nonresolving posttransfusion non-A, non-B hepatitis. Scand J Infect Dis 1990; 22: 11–17
   PubMedGoogle Scholar
• Ramadori G, Zöhrens G, Manns M, Rieder H, Dienes H P., Hess G, Meyer zum Buschenfelde K-H. Serum hyaluronate and type III procollagen aminoterminal propeptide concentration in chronic liver disease. Relationship to cirrhosis and disease activity. Eur J Clin Invest 1991; 21: 323–30
   PubMed Web of Science ®Google Scholar
• Bentsen K D., Horn T, Risteli J, Risteli L, Engström-Laurent A, Hörslev-Petersen K, Lorenzen I. Serum aminoterminal type III procollagen peptide and the 7S domain of type IV collagen in patients with alcohol abuse. Relation to ultrastructural fibrosis in the acinar zone 3 and to serum hyaluronan. Liver 1987; 7: 339–46
   PubMedGoogle Scholar
• Dahl I MS, Laurent T C. Concentration of hyaluronan in serum of untreated cancer patients with special reference to patients with mesothelioma. Cancer 1988; 62: 326–30
   PubMed Web of Science ®Google Scholar
• Wu A HB, Parker O S., Ford L. Hyperviscosity caused by hyaluronic acid in serum in a case of Wilms- tumor. Clin Chem 1984; 30: 914–6
   PubMed Web of Science ®Google Scholar
• Manley G, Warren C. Serum hyaluronic acid in patients with disseminated neoplasm. J Clin Pathol 1987; 40: 626–30
   PubMed Web of Science ®Google Scholar
• Chichibu K, Matsuura T, Shichijo S, Yokoyama M M. Assay of serum hyaluronic acid in clinical application. Clin Chim Acta 1989; 181: 317–24
   PubMed Web of Science ®Google Scholar
• Berg S, Brodin B, Hesselvik F, Laurent T C., Mailer R. Elevated levels of plasma hyaluronan in septicaemia. Scand J Clin Lab Invest 1988; 48: 727–32
   PubMed Web of Science ®Google Scholar
• Miller E J. Chemistry of the collagcns and their distribution. Extracellular matrix biochemistry, K A. Piez, A H. Reddi. Elsevier, New York 1984; 41–81
   Google Scholar
• Rohde H, Vargas L, Hahn E, Kalbfleisch H, Bruguera M, Timpl R. Radioimmunoassay for type III procollagen peptide and its application to human liver disease. Eur J Clin Invest 1979; 9: 451–9
   PubMed Web of Science ®Google Scholar
• Niemelä O, Risteli L, Sotaniemi E A., Risteli J. Aminoterminal propeptide of type III procollagen in serum in alcoholic liver disease. Gastroenterology 1983; 85: 254–9
   PubMed Web of Science ®Google Scholar
• Annoni G, Donato M F., Cantaluppi C, Lampertico P, Cargncl A, Vigano P, Hahn G E., Colombo M. Serum procollagen type III peptide in patients with acute viral hepatitis. La Ricerca Clin Lab 1988; 18: 37–44
   PubMedGoogle Scholar
• Bentsen K D., Hörslev-Petersen K, Junker P, Juhl E, Lorenzen I. Serum aminoterminal procollagen type III peptide in acute viral hepatitis. A long-term follow-up study. Liver 1987; 7: 96–105
   PubMedGoogle Scholar
• Mattsson L, Lindqvist U, Weiland O, Åberg B. Serum levels of the aminoterminal propeptide of type III procollagen and hyaluronan during resolving and nonresolving posttransfusion non-A, non-B hepatitis. Scand J Infect Dis 1990; 22: 11–7
   PubMed Web of Science ®Google Scholar
• Frei A, Zimmermann A, Weigand K. The N-terminal propeptide of collagen type III in serum reflects activity and degree of fibrosis in patients with chronic liver disease. Hepatology 1984; 4: 830–4
   PubMed Web of Science ®Google Scholar
• Babbs C, Hunt L P., Haboubi N Y., Smith A, Rowan B, Warnes T W. Type III procollagen peptide: A markerof disease activity and prognosis in primary biliary cirrhosis. Lancet 1988; i: 1021–4
   Google Scholar
• Hatahara T, Igarashi S, Funaki N. High concentrations of N-terminal peptide of type III procollagen in the sera of patients with various cancers, with special reference to liver cancer. Gann 1984; 75: 130–5
   PubMedGoogle Scholar
• Bolarin D M., Savolainen E-R, Kivirikko K I. Enzymes of collagen synthesis and type III procollagen amino-peptide in serum from Nigerians with hepatocellular carcinoma and other malignant diseases. Int J Cancer 1982; 29: 401–5
   PubMed Web of Science ®Google Scholar
• Simon L S., Krane S M., Wortman P D., Krane I M., Kovitz K L. Scrum levels of type I and III procollagen fragments in Paget's disease of bone. J Clin Endocr Metab 1984; 58: 110–20
   PubMed Web of Science ®Google Scholar
• Hochwciss S, Fruchtman S, Hahn E G., Gilbert H, Donovan P B., Johnson J, Goldberg J D., Berk P D. Increased serum procollagen III aminoterminal peptide in myelofibrosis. Am J Hcmatol 1983; 15: 343–51
   PubMed Web of Science ®Google Scholar
• Hasselbalch H, Junker P, Lisse I, Lindqvist U, Engström-Laurent A. Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders. Am J Hem 1991; 36: 1–8
   PubMed Web of Science ®Google Scholar
• Smedsröd B. Aminoterminal propeptide of type III procollagen is cleared from the circulation by receptor-mediated endocytosis in liver endothelial cells. Coll Rel Res 1988; 8: 375–88
   PubMedGoogle Scholar
• Trivedi P, Cheeseman P, Portmann B, Hegarty J, Mowat A P. Variation in serum type III procollagen peptide with age in healthy subjects and its comparative value in the assessment of disease activity in children with chronic active hepatitis. Eur J Clin Invest 1985; 15: 69–74
   PubMed Web of Science ®Google Scholar
• Risteli L, Puistola U, Hohtari H, Kauppila A, Risteli J. Collagen metabolism in normal and complicated pregnancy: changes in the amino-termina! propeptide of type III procollagen in serum. Europ J Clin Invest 1987; 17: 81–6
   PubMed Web of Science ®Google Scholar
• Nyberg A, Lindqvist U, Engström-Laurent A. Serum hyaluronan and aminoterminal propeptide of type III procollagen in primary biliary cirrhosis. J Int Med 1992; 231: 485–91
   PubMed Web of Science ®Google Scholar
• Bentsen K D., Henrtsksen J H., Boesby S, Hörslev-Petersen K, Lorenzen I. Hepatic and renal extraction of circulating type III procollagen aminoterminal propeptide and hyaluronan in pig. J Hepatol 1989; 9: 177–83
   PubMed Web of Science ®Google Scholar
• Jensen L T., Olesen H P., Risteli J, Lorenzen I. External thoracic duct-venous shunt in conscious pigs for long term studies of connective tissue metabolites in lymph. Lab Anim Sci 1990; 6: 620–4
   Google Scholar
• Colombel J F., Hällgren R, Engström-Laurent A, Rambaud J C. Hyaluronic acid and type III procollagen peptide in jejunal perfusion fluid as markers of connective tissue turnover. Gastroenterology 1989; 96: 68–73
   PubMed Web of Science ®Google Scholar
• Faber J, Hörslev-Petersen K, Perrild H, Lorenzen I. Different effects of thyroid disease on serum levels of procollagen III N-peptide and hyaluronic acid. J Clin Endocrinol Metab. 1990; 71: 1016–21
   PubMed Web of Science ®Google Scholar
• Österlind P O., Alafuzoff I, Löfgren A C., Marklund S, Nystrom L, Sandman P-O, Steen B, Winblad B. Blood components in an elderly population. Gerontology 1984; 30: 247–52
   PubMed Web of Science ®Google Scholar
• Brandt R, Hedlöf E, Åsman I, Bucht A, Tengblad A. A convenient radiometric assay for hyaluronan. Acta Otolaryngol (Stockh) 1987, Suppl. 442: 31–5
   Google Scholar
• Laurent T C., Fraser J RE. Catabolism of hyaluronan. Degradation of bioactive substances: Physiology and pathophysiology, J H. Henriksen. CRC Press, Boca Raton 1991; 249–65
   Google Scholar
• Lindqvist U, Engström-Laurent A, Laurent U, Nyberg A, Björklund U, Eriksson H, Pettersson R, Tengglad A. The diurnal variation of serum-hyaluronan in health and disease. Scand J Clin Lab Invest 1988; 48: 765–70
   PubMed Web of Science ®Google Scholar
• Ljungdahl L. Kreatinin i urin (U-Kreatinin). Klinisk kemi i praktisk medicin, Lund, Student-litteratur, P Fernlund, A Hansson, C-B Laurell, B Lund, 1986; 441–2
   Google Scholar
• Henriksen J H., Bentsen K D., Laurent T C. Splanchnic and renal extraction of circulating hyaluronan in patients with alcoholic liver disease. J Hepatology 1988; 6: 158–66
   PubMed Web of Science ®Google Scholar
• Laurent T C., Fraser J RE. Catabolism of hyaluronan. Degradation of Bioactive Substances: Physiology and Pathophysiology, Henriksen H. Jens. CRC Press, Boca Raton 1991; 249–65
   Google Scholar
• Fessler J H., Fessler L I. Biosynthesis of procollagen. Annu Rev Biochem 1978; 47: 129–62
   PubMed Web of Science ®Google Scholar
• Raedsch R, Stiehl A, Sieg A, Walker S, Kommerell B. Biliary excretion of procollagen type III peptide in healthy humans and in patients with alcoholic cirrhosis of the liver. Gastroenterology 1983; 85: 1265–70
   PubMed Web of Science ®Google Scholar
• Fraser J RE, Dahl L B., Kimpton W G., Cahil R NP, Brown T J., Vakakis N. Elimination and subsequent metabolism of circulating hyaluronic acid in the fetus. J Develop Physiol 1989; 11: 235–42
   PubMedGoogle Scholar
• Dahl L B., Kimpton W G., Cahill R PN, Brown T J., Fraser J RE. The origin and fate of hyaluronan in amniotic fluid. J Develop Physiol 1989; 12: 209–18
   PubMedGoogle Scholar